http://web.archive.org/web/20140813014410id_/http://www.dailymail.co.uk/news/article-2719446/FDA-lifts-hold-experimental-Ebola-drug.html

by @entity0 and @entity1 @entity3 health authorities have eased safety restrictions on an experimental drug to treat @entity6 , a move that could clear the way for its use in patients infected with the deadly virus			1
@entity13 drugmaker @entity12 said the @entity14 modified a hold recently placed on the company 's drug after safety issues emerged in human testing			1
the company has a $ 140 million contract with the @entity3 government to develop its drug , @entity6 , which targets the genetic material of @entity6			1
but last month the @entity14 halted a small study of the injection in adults to request additional safety information			1
@entity29 said thursday the agency ' verbally confirmed ' changes to the hold that may allow the company to make the drug available , although it has yet to be proven as safe and effective			1
it is aimed at boosting the immune system 's efforts to fight off @entity6 and is made from antibodies produced by lab animals exposed to parts of the virus			2
@entity6 helped four @entity6 - ridden monkeys four years ago and ' worked to protect them from the disease , ' @entity55 reported			2
the @entity3 aid workers were first treated in @entity60			0
and while the @entity14 must grant permission to use experimental treatments in the @entity3 , it does not have authority over the use of such a drugs in other countries			1
the @entity14 's move thursday comes amid an @entity6 outbreak in @entity70 that health officials warn could sicken more people than all previous outbreaks of the disease combined			1
more than 1,700 people have been sickened in the current outbreak , which began in march			0
nearly 1,000 have died , according to the @entity77			0
currently , there are no licensed drugs or vaccines for the deadly disease			0
several are in various stages of development , but none have been rigorously tested in humans			0
treatment : currently , there are no licensed drugs or vaccines for the ebola virus the @entity14 in march granted @entity29 ' fast track ' status for its @entity6 drug , a designation designed to speed up approval of high - priority drugs by granting companies extra meetings with @entity14 scientists			1
early studies of @entity6 in monkeys suggested it could block high doses of the ebola virus			0
but on july 21 , the company based in @entity106 , @entity107 , announced the @entity14 had halted a small dosing study of the drug in 28 healthy adults			1
the company said regulators had questions about a type of drug reaction that can cause nausea , chills , low blood pressure and shortness of breath			0
@entity29 's ceo @entity120 praised the @entity14 for modifying the restriction on thursday			2
' we have been closely watching the ebola virus outbreak and its consequences , and we are willing to assist with any responsible use of @entity6 , ' @entity120 said in a release			0
' the foresight shown by the @entity14 removes one potential roadblock to doing so			0
' @entity14 spokeswoman @entity129 said she could not confirm the company 's announcement since @entity14 regulations bar the agency from disclosing information about experimental drugs			1
she did note that the agency places clinical holds on studies based on the risks and benefits to patients			0
patients in the @entity29 study were healthy volunteers			2
on friday , @entity29 's stock opened at $ 16.52			2
as of this writing , stock prices increased to $ 19.80 .			0

@entity12 has a $ 140 million contract with the @entity3 government to develop its drug , @entity6 , which targets the genetic material of @entity6
last month the @entity14 halted a small study of the injection in adults to request additional safety information
@entity29 said thursday the agency ' verbally confirmed ' changes to the hold that may allow the company to make the drug available
the drug has yet to be proven as safe and effective
two @entity3 diagnosed with @entity6 recently received a different experimental drug called @entity45 , made by @entity46

@entity3:Americans
@entity1:Zoe Szathmary
@entity0:Associated Press
@entity13:Canadian
@entity6:Ebola
@entity29:Tekmira
@entity60:Liberia
@entity70:West Africa
@entity45:ZMapp
@entity46:Mapp Biopharmaceutical Inc.
@entity14:FDA
@entity120:Murray
@entity106:Vancouver
@entity107:British Columbia
@entity12:Tekmira Pharmaceuticals Corp.
@entity47:San Diego
@entity77:World Health Organization
@entity129:Stephanie Yao
@entity55:Bloomberg.com